Brian Gazzard

34.3k total citations · 5 hit papers
494 papers, 21.8k citations indexed

About

Brian Gazzard is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Brian Gazzard has authored 494 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 274 papers in Infectious Diseases, 196 papers in Virology and 177 papers in Epidemiology. Recurrent topics in Brian Gazzard's work include HIV Research and Treatment (195 papers), HIV/AIDS drug development and treatment (188 papers) and HIV/AIDS Research and Interventions (138 papers). Brian Gazzard is often cited by papers focused on HIV Research and Treatment (195 papers), HIV/AIDS drug development and treatment (188 papers) and HIV/AIDS Research and Interventions (138 papers). Brian Gazzard collaborates with scholars based in United Kingdom, United States and France. Brian Gazzard's co-authors include Mark Nelson, Sundhiya Mandalia, Mark Bower, Graeme Moyle, Justin Stebbing, Frances Gotch, Anton Pozniak, Michael S. Saag, John Walsh and Robert T. Schooley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Brian Gazzard

487 papers receiving 20.8k citations

Hit Papers

Antiretroviral Therapy in... 2000 2026 2008 2017 2000 2006 2006 2004 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antiretroviral Therapy in Adults
    2000 874 citations Brian Gazzard et al. profile →
  2. Treatment for Adult HIV Infection
    2006 767 citations Brian Gazzard et al. profile →
  3. Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
    2006 703 citations Brian Gazzard et al. profile →
  4. Treatment for Adult HIV Infection
    2004 601 citations Brian Gazzard et al. profile →
  5. Antiretroviral Treatment for Adult HIV Infection in 2002
    2002 573 citations Brian Gazzard et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Brian Gazzard 12.2k 8.9k 7.0k 3.3k 3.2k 494 21.8k
Dominique Costagliola 9.0k 0.7× 7.3k 0.8× 5.6k 0.8× 3.9k 1.2× 2.7k 0.8× 450 17.8k
John Phair 11.0k 0.9× 9.5k 1.1× 7.6k 1.1× 3.0k 0.9× 2.2k 0.7× 353 22.0k
Adriano Lazzarin 12.2k 1.0× 10.9k 1.2× 6.2k 0.9× 3.4k 1.0× 1.9k 0.6× 616 20.6k
Margaret A. Fischl 16.5k 1.4× 12.5k 1.4× 6.8k 1.0× 3.4k 1.0× 1.4k 0.4× 268 23.5k
Jean‐Michel Molina 11.4k 0.9× 7.2k 0.8× 5.9k 0.8× 2.6k 0.8× 1.3k 0.4× 547 18.7k
Scott D. Holmberg 14.4k 1.2× 7.3k 0.8× 13.5k 1.9× 4.7k 1.4× 1.8k 0.5× 200 26.9k
Jeffrey N. Martin 11.7k 1.0× 11.6k 1.3× 6.7k 1.0× 5.3k 1.6× 1.8k 0.6× 340 23.5k
Antonella d’Arminio Monforte 14.6k 1.2× 9.5k 1.1× 6.7k 1.0× 8.8k 2.6× 1.5k 0.5× 485 21.9k
Paul A. Volberding 13.9k 1.1× 10.0k 1.1× 5.8k 0.8× 3.0k 0.9× 1.6k 0.5× 191 19.8k
Henry Masur 10.4k 0.9× 6.1k 0.7× 17.4k 2.5× 2.6k 0.8× 2.0k 0.6× 375 33.5k

Countries citing papers authored by Brian Gazzard

Since Specialization
Citations

This map shows the geographic impact of Brian Gazzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gazzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gazzard more than expected).

Fields of papers citing papers by Brian Gazzard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Gazzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gazzard. The network helps show where Brian Gazzard may publish in the future.

Co-authorship network of co-authors of Brian Gazzard

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Gazzard. A scholar is included among the top collaborators of Brian Gazzard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Gazzard. Brian Gazzard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hill, Andrew, Will Sawyer, & Brian Gazzard. (2009). Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels. HIV Clinical Trials. 10(1). 1–12. 42 indexed citations
2.
Powles, Thomas, David Robinson, Justin Stebbing, et al.. (2008). Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection. Journal of Clinical Oncology. 27(6). 884–890. 269 indexed citations
3.
Gazzard, Brian & Graeme Moyle. (1999). Commentary: resistance testing--a clinical perspective.. Sexually Transmitted Infections. 75(3). 141–2. 1 indexed citations
4.
Sharpstone, D, Penny Neild, R Crane, et al.. (1999). Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut. 45(1). 70–76. 107 indexed citations
5.
Sharpstone, D, Anthony W. Rowbottom, Michael J. Nelson, & Brian Gazzard. (1996). Faecal alpha 1 antitrypsin as a marker of gastrointestinal disease in HIV antibody positive individuals.. Gut. 38(2). 206–210. 9 indexed citations
6.
Keating, J. J., Ingvar Bjarnason, Siva G. Somasundaram, et al.. (1995). Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea.. Gut. 37(5). 623–629. 113 indexed citations
7.
Blanshard, C & Brian Gazzard. (1995). Natural history and prognosis of diarrhoea of unknown cause in patients with acquired immunodeficiency syndrome (AIDS).. Gut. 36(2). 283–286. 37 indexed citations
8.
Sarin, Prem S., Paul H. Naylor, Jeffrey Kahn, et al.. (1994). Cytotoxic and humoral immune responses to HIV-1 p17 synthetic peptide HGP-30 in human volunteers. 3(1). 49–57. 1 indexed citations
9.
Vandamme, Anne–Mieke, Zeger Debyser, Rudi Pauwels, et al.. (1994). Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913. AIDS Research and Human Retroviruses. 10(1). 39–46. 36 indexed citations
10.
Hickman, Matthew, et al.. (1993). AIDS surveillance: a direct assessment of under-reporting. AIDS. 7(12). 1661–1665. 7 indexed citations
11.
Barton, Simon, et al.. (1993). HIV and AIDS : your questions answered. Churchill Livingstone eBooks.
12.
Blanshard, C, Christopher S. Peacock, D G Tovey, et al.. (1992). Simultaneous infection with two types of intestinal microsporidia in a patient with AIDS.. Gut. 33(3). 418–420. 34 indexed citations
13.
Connolly, G M, Alastair Forbes, & Brian Gazzard. (1990). Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1.. Gut. 31(8). 886–889. 51 indexed citations
14.
Connolly, G M, et al.. (1989). Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients.. Gut. 30(2). 195–200. 65 indexed citations
15.
Connolly, G M, Matthew Dryden, D.C. Shanson, & Brian Gazzard. (1988). Cryptosporidial diarrhoea in AIDS and its treatment.. Gut. 29(5). 593–597. 104 indexed citations
16.
Filipe, M I, F Potet, Wladimir V. Bogomoletz, et al.. (1985). Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres.. Gut. 26(12). 1319–1326. 159 indexed citations
17.
Shanson, D.C. & Brian Gazzard. (1984). Kingella kingae septicaemia with a clinical presentation resembling disseminated gonococcal infection.. BMJ. 289(6447). 730–731. 10 indexed citations
18.
Lance, Peter & Brian Gazzard. (1983). Ulcerative enteritis and liver disease in a patient with coeliac disease.. Gut. 24(5). 433–437. 5 indexed citations
19.
Filipe, M I, et al.. (1982). Mucin secretion in inflammatory bowel disease: correlation with disease activity and dysplasia.. Gut. 23(6). 485–489. 93 indexed citations
20.
Gazzard, Brian, H. L. Price, Gerald Libby, & A M Dawson. (1978). The social toll of Crohn's disease.. BMJ. 2(6145). 1117–1119. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Costagliola Breakdown of academic impact, for papers by John Phair Breakdown of academic impact, for papers by Adriano Lazzarin Breakdown of academic impact, for papers by Margaret A. Fischl Breakdown of academic impact, for papers by Jean‐Michel Molina Breakdown of academic impact, for papers by Scott D. Holmberg Breakdown of academic impact, for papers by Jeffrey N. Martin Breakdown of academic impact, for papers by Antonella d’Arminio Monforte Breakdown of academic impact, for papers by Paul A. Volberding Breakdown of academic impact, for papers by Henry Masur
Rankless by CCL
2026